1. Crawford, J, Dale, DC, Lyman, GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 2004; 100: 228–237.
Google Scholar | Crossref | Medline | ISI2. Lyman, GH, Dale, D, Friedberg, J, et al. Incidence and predictors of low chemotherapy dose intensity in aggressive non-Hodgkin’s Lymphoma: a nation wide study. J Clin Oncol 2004; 22: 4302–4311.
Google Scholar | Crossref | Medline | ISI3. Morrison VA, P, Scott, S, Pohlman, B, et al. The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin’s Lymphoma receiving initial CHOP chemotherapy: a risk factor analysis. Clin Lymphoma 2001; 2: 47–56.
Google Scholar | Crossref | Medline4. Schwenkglenks, M, Jackisch, C, Constenla, M, et al. Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment. Support Care Cancer 2006; 14: 901–909.
Google Scholar | Crossref | Medline5. Todd, A, Copeland, A, Husband, A, et al. Access allareas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open 2015; 5: e007328.
Google Scholar | Crossref | Medline6. Lum, BL, McWaters, DS, Mergener, MA. Cancer detection and the community pharmacist. Am Pharm 1989; 29: 54–59. PMID: 2763979.
Google Scholar | Crossref7. Mensah, KB, Oosthuizen, F, Bonsu, AB. Cancer awareness among community pharmacist: a systematic review. BMC Cancer 2018; 18: 299–307.
Google Scholar | Crossref | Medline8. Mayer, JA, Eckhardt, L, Stepanski, BM, et al. Promoting skin cancer prevention counseling by pharmacists. Am J Public Health 1998; 88: 1096–1099.
Google Scholar | Crossref | Medline | ISI9. Al-Arifi, MN . Patients’ perception, views and satisfaction with pharmacists’ role as health care provider in community pharmacy setting at Riyadh, Saudi Arabia. Saudi Pharm J 2012; 20: 323–330. Epub 2012 May 26. PMID: 23960807; PMCID: PMC3745196.
Google Scholar | Crossref | Medline10. Mensah, KB, Bangalee, V, Oosthuizen, F. Assessing knowledge of community pharmacists on cancer: a pilot study in Ghana. Front Public Health 2019; 7: 13. PMID: 30775358; PMCID: PMC6367248.
Google Scholar | Crossref | Medline11. Beshir, SA, Hanipah, MA. Knowledge, perception, practice and barriers of breast cancer health promotion activities among community pharmacists in two Districts of Selangor state, Malaysia. Asian Pac J Cancer Prev 2012; 13: 4427–4430. PMID: 23167355.
Google Scholar | Crossref | Medline12. Chua, SS, Lim, KP, Lee, HG. Utilisation of community pharmacists by the general public in Malaysia. Int J Pharm Pract 2013; 21: 66–69.
Google Scholar | Crossref | Medline13. Freifeld, AG, Bow, EJ, Sepkowitz, KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011; 52: e56–e93. PMID: 21258094.
Google Scholar | Crossref | Medline | ISI